Microglia-Mediated Synapse Loss in Alzheimer's Disease

Area of Science:

• Neuroscience
• Immunology
• Cell Biology

Background:

• Microglia are brain immune cells increasingly recognized for their role in neurodegenerative diseases like Alzheimer's disease (AD).
• Traditionally viewed as modulators of neuroinflammation, recent evidence highlights their direct role in neuronal damage.
• This includes the phagocytosis of neuronal and synaptic components, contributing to neurodegeneration in AD.

Purpose of the Study:

• To review recent findings on the direct role of microglia in Alzheimer's disease (AD) pathogenesis.
• To explore the cellular mechanisms underlying microglia-mediated neurodegeneration.
• To discuss the influence of genetic risk factors and sleep on these processes and potential therapeutic targets.

Main Methods:

• Literature review of recent studies on microglia function in Alzheimer's disease.
• Analysis of cellular mechanisms involved in microglia-mediated phagocytosis of neuronal structures.
• Discussion of potential regulatory roles of AD risk genes and sleep.

Main Results:

• Microglia actively contribute to neurodegeneration in AD by phagocytosing neuronal and synaptic structures.
• This process can occur independently of amyloid-beta peptides, underscoring microglia's central role.
• Emerging evidence suggests regulation by AD risk genes and sleep patterns.

Conclusions:

• Microglia play a direct, significant role in the neurodegenerative processes of Alzheimer's disease.
• Understanding microglia-mediated synapse loss is crucial for developing novel therapeutic and preventive strategies for AD.
• Targeting these mechanisms, potentially influenced by genetics and sleep, offers promising avenues for AD treatment.